摘要：Scientific Reports 5 : Article number: 9530 10.1038/srep09530 ; published online: 01 April 2015 ; updated: 05 August 2015 . This Article contains a typographical error in the Results section under subheading ‘Identification of F12016 as a novel selective PPARγ agonist distinct from rosiglitazone’. “The chemical name of F12016 is 2-[2-(1, 2-dimethyl-1H-indol-3-yl)-2-oxo-acetylamino]-benzamide, which has not been reported to show any activity.
